Details for New Drug Application (NDA): 022272
✉ Email this page to a colleague
The generic ingredient in OXYCONTIN is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
Summary for 022272
Tradename: | OXYCONTIN |
Applicant: | Purdue Pharma Lp |
Ingredient: | oxycodone hydrochloride |
Patents: | 18 |
Pharmacology for NDA: 022272
Mechanism of Action | Full Opioid Agonists |
Suppliers and Packaging for NDA: 022272
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272 | NDA AUTHORIZED GENERIC | Teva Pharmaceuticals USA, Inc. | 0093-5731 | 0093-5731-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-5731-01) |
OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272 | NDA AUTHORIZED GENERIC | Teva Pharmaceuticals USA, Inc. | 0093-5732 | 0093-5732-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0093-5732-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
Approval Date: | Apr 5, 2010 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 30, 2025 | Product Flag? | Substance Flag? | Y | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 30, 2025 | Product Flag? | Substance Flag? | Y | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 24, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 022272
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-001 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-007 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-007 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-007 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-003 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription